3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Status
Terminated
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Head & Neck
1
Conditions
Lung Neoplasms
4
Neoplasms
3
Breast Neoplasms
3
Uterine Cervical Neoplasms
2
Depression
2
Vulvar Neoplasms
1
Vomiting
1
Stomach Neoplasms
1
Patient Compliance
1
Pancreatic Neoplasms
1
Non-resectable Metastatic Cancer of the Lung
1
Neuroblastoma
1
Nausea
1
Leukemia
1
Laryngeal Diseases
1
Hematologic Neoplasms
1
Endometrial Neoplasms
1
Carcinoma, Non-Small-Cell Lung
1
Brain Neoplasms
1
Anxiety Disorders
1
Anus Neoplasms
1
Interventions
Cetuximab
3
N-benzhydryl-5-(2-(methylamino)propanamido)-3-(3-methylbutanoyl)-6-oxodecahydropyrrolo(1,2-a)(1,5)diazocine-8-carboxamide
2
Cisplatin
2
capmatinib
1
Surveys and Questionnaires
1
Radiotherapy, Intensity-Modulated
1
Radiotherapy, Adjuvant
1
Radiotherapy
1
Proflavine
1
Modafinil
1
Minocycline
1
Laryngectomy
1
Interviews as Topic
1
Emulsions
1
Chemoradiotherapy
1
Bupropion
1
Bleomycin
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Terminated
×
Laryngeal Diseases
×
Interviews as Topic
×
Clear all
NCT01647477
2026-03-13
DEREDIA
Centre Oscar Lambret
Phase NA
Terminated
90 enrolled